Cannabis in Brazil

Cannabis in Brazil

2022 was an interesting and intense year for the cannabis market in Brazil. New products hit the market, produced by Brazilian companies that are becoming more and more complex as well as better funded, allowing for a wider range of consumers to access medical cannabis. At the same time, legal uncertainty put prescribing doctors and users in a tight spot, with CFM (Conselho Federal de Medicina)’s decision to recommend cannabis use only for the treatment of epilepsy. Although the decision lasted...

Euromonitor International's Cannabis in Brazil market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth. It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market – legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2026 illustrate how the market is set to expand and change.

Product coverage: Adult-Use Cannabis, CBD, Medical Cannabis.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cannabis market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.